121 noterade bolag på Stockholmsbörsen.
| Bolag | Börsvärde |
|---|---|
| EQL Pharma AB LUND | 1.6 mdkr |
| Surgical Science Sweden AB GÖTEBORG | 1.6 mdkr |
| BioInvent International AB Lund | 1.5 mdkr |
| Medivir AB HUDDINGE | 1.4 mdkr |
| Xspray Pharma AB SOLNA | 1.4 mdkr |
| Genovis AB Kävlinge | 1.3 mdkr |
| BICO Group AB Class B GÖTEBORG | 1.3 mdkr |
| HAMLET BIOPHARMA AB CLASS B LUND | 1.3 mdkr |
| Devyser Diagnostics AB ÅRSTA | 1.3 mdkr |
| Paxman AB Karlshamn | 1.1 mdkr |
| Cantargia AB LUND | 975 mkr |
| SynAct Pharma AB LUND | 955 mkr |
| Sedana Medical AB DANDERYD | 922 mkr |
| C-Rad AB Class B UPPSALA | 915 mkr |
| Dicot Pharma AB UPPSALA | 791 mkr |
| Cinclus Pharma Holding AB STOCKHOLM | 765 mkr |
| Orexo AB UPPSALA | 732 mkr |
| Enzymatica AB LUND | 731 mkr |
| Senzime AB | 719 mkr |
| Infant Bacterial Therapeutics AB Class B STOCKHOLM | 670 mkr |
| Nanexa AB UPPSALA | 642 mkr |
| FluoGuide A/S | 633 mkr |
| Bactiguard Holding AB Stockholm | 589 mkr |
| Doxa AB MALMÖ | 541 mkr |
| Oncopeptides AB Stockholm | 524 mkr |
| Nanoform Finland Oyj | 511 mkr |
| Moberg Pharma AB BROMMA | 474 mkr |
| Corline Biomedical AB UPPSALA | 411 mkr |
| Q-linea AB UPPSALA | 410 mkr |
| OssDsign AB UPPSALA | 387 mkr |
| Sprint Bioscience AB HUDDINGE | 386 mkr |
| Ascelia Pharma AB MALMÖ | 377 mkr |
| Mentice AB GÖTEBORG | 374 mkr |
| BIO-WORKS TECHNOLOGIES AB UPPSALA | 344 mkr |
| Acarix AB MALMÖ | 331 mkr |
| SciBase Holding AB STOCKHOLM | 311 mkr |
| Mendus AB Mölndal | 306 mkr |
| Klaria Pharma Holding AB UPPSALA | 300 mkr |
| Intervacc AB HÄGERSTEN | 286 mkr |
| Elicera Therapeutics AB GÖTEBORG | 274 mkr |
| Promimic AB MÖLNDAL | 259 mkr |
| BrainCool AB LUND | 253 mkr |
| Xintela AB LUND | 245 mkr |
| Initiator Pharma A/S | 224 mkr |
| Medclair AB SKARPNÄCK | 214 mkr |
| Prolight Diagnostics AB LUND | 212 mkr |
| Diamyd Medical AB Class B STOCKHOLM | 197 mkr |
| Isofol Medical AB GÖTEBORG | 193 mkr |
| Integrum AB Class B MÖLNDAL | 189 mkr |
| DEXTECH MEDICAL AB UPPSALA | 187 mkr |